|
The
serotonin and/or catecholamine
system has a role, either
directly or indirectly, in
controlling most of the other
systems and functions in the
body. For example, cortisol
synthesis is controlled in part by
norepinephrine. Hormone
synthesis is dependent on
norepinephrine. The sympathetic
nervous system is controlled by
norepinephrine. Other
neurotransmitter systems are
partially controlled by the
serotonin and/or catecholamine
systems. For example, the GABA
neurotransmitter system is
associated with control of
anxiety and panic attacks. Yet
when the serotonin and/or
catecholamine neurotransmitter
levels are brought to proper
levels, as confirmed by lab
testing, these diseases may be
fully under control. This would
indicate control of GABA by the
serotonin / catecholamine system
even though at this time we have
been unable to identify a
chemical pathway for such in the
literature. The point is, if
GABA is of concern addressing
serotonin and dopamine is the
proper way to deal with these
concerns.
|
|
|
|
Its no secret, NeuroResearch Clinics uses the nutrients 5-HTP, tyrosine, levodopa,
and cysteine to treat medical
patients in order to get these
results. Proper
use of these simple ingredients in
medical treatment is not simple.
From time to time a patient will
say, "Why do I want to take that, I
can go to a health food store and
buy it?" People off the street
buying in a health food store is
like going to an art store and
buying a bunch of oil paints then
going home and expecting to paint
like a mater artist even though
there was no previous painting
experience. These nutrients have
tremendous potential due to their
chemical properties. This potential
is only fully realized in the hands
of the trained professional using
neurotransmitter testing. Treatment
is not just giving a nutrient pill, it is the whole medical management approach doctors are trained in to insure that that treatment is on track in order to get symptoms under control.
The Peer Reviewed Research
of NeuroResearch Clinics
The neurotransmitter treatment research findings of NeuroResearch Clinics
have not been ignored. The University of
Minnesota Medical School is writing a series of
papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "NeuroPsychiatric Disease and Treatment" May 1, 2009. Ingrid
Kohlstadt, MD of Johns Hopkins in her new
medical text book released February 7, 2009
included a chapter on depression written by
Marty L. Hinz, MD President Clinical
Research NeuroResearch Clinics outlining in
depth the proper use of amino acids and
neurotransmitter testing in treatment of
depression.
|
